Sentinel Lymph Node Biopsy Imaging Agents Market Share To Reach Scalable Heights Of Growth
The global sentinel lymph node biopsy imaging agents market size was estimated at USD 101.48 million in 2025 and is projected to reach USD 184.10 million by 2033, growing at a CAGR of 7.96% from 2026 to 2033. The market is primarily driven by the rising global burden of cancer, particularly breast cancer and melanoma, which is increasing the need for accurate staging and precise lymphatic mapping techniques. Sentinel lymph node biopsy (SLNB) has become an essential procedure in oncology because it enables physicians to determine whether cancer has spread to nearby lymph nodes while minimizing the need for more extensive surgical interventions. As healthcare systems increasingly shift toward minimally invasive diagnostic and surgical procedures, SLNB is being preferred over full lymph node dissection due to its ability to reduce complications such as lymphedema, lower postoperative pain, shorten hospital stays, and support faster patient recovery. These clinical advantages are signific...